(Q39733396)

14 September 2017

title

Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications (English)

1 reference

14 September 2017

1 reference

Theodoropoulos VE

1

1 reference

14 September 2017

Tsigka A

2

1 reference

14 September 2017

Mihalopoulou A

3

1 reference

14 September 2017

Tsoukala V

4

1 reference

14 September 2017

Lazaris AC

5

1 reference

14 September 2017

Patsouris E

6

1 reference

14 September 2017

Ghikonti I

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

14 September 2017

1 reference

14 September 2017

volume

66

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

897-902

1 reference

Incidental carcinoma of the prostate: an analysis of the predictors of progression

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neurogenic origin of human prostate endocrine cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neuro-endocrine cells--a new prognostic parameter in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neuroendocrine differentiation and prognosis in prostatic adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Relationship between androgen receptor binding activity in human prostate cancer and clinical response to endocrine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Results of conservative management of clinically localized prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neuroendocrine differentiation in human prostatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Modulation of Prostate Carcinoma Cell Growth and Apoptosis by Chromogranin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neuroendocrine differentiation is not prognostic of failure after radical prostatectomy but correlates with tumor volume

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Neurotransmitters as growth regulatory signals: role of receptors and second messengers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

Androgen receptor expression in prostatic intraepithelial neoplasia and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.04.064

10.1016/J.UROLOGY.2005.04.064

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference